How much is the latest price of capmatinib per box?
Capmatinib is a drug used to treat a specific type of lung cancer. It belongs to a class of drugs called tyrosine kinase inhibitors, which are mainly used to target abnormal activity of protein kinases, thereby blocking the growth and spread of cancer cells.
Capmatinib is not currently available in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same.

This drug specifically targetsMET (lung adenocarcinoma-associated kinase). METkinase has the function of regulating cell growth and differentiation under normal physiological conditions. However, in some cases, METkinase may be abnormally activated, leading to abnormal proliferation of cancer cells. Capmatinib prevents this abnormal proliferation by inhibiting the activity of MET kinase, thus having a positive effect on the treatment of lung cancer.
Generally, capmatinib may be used to treat METpositive non-small cell lung cancer (NSCLC). Non-small cell lung cancer is one of the main types of lung cancer, and MET positivity means that MET kinase is abnormally active in cancer cells. The use of capmatinib may help prolong patient survival and improve quality of life.
It is worth noting that the specific use of capmatinib should be determined by a professional medical team based on the patient's specific condition, because the drug may cause some side effects and interactions. During treatment, patients need to receive regular medical monitoring to ensure the efficacy and safety of the drug.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)